Feb 4 (Reuters) - Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to ...
Mark Cuban critiques the FTC Cigna Express Scripts settlement, citing limited reforms and concerns over rebate ...
According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...
Cigna is hoping the settlement it reached with regulators paired with recent legislation will mollify calls to reform PBMs — ...
Express Scripts agreed to overhaul its business model, ensuring patients pay the lowest available price for medications and ...
The settlement comes after the FTC in September 2024 brought action against three prescription drug benefit managers, including Express Scripts, alleging the companies were artificially inflating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results